Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sunflower lecithin is a phospholipid-rich substance derived from sunflower seeds, primarily composed of phosphatidylcholine, phosphatidylethanolamine, and phosphatidylinositol. In the context of clinical research at McMaster University, sunflower lecithin oil capsules have been utilized as a placebo control in randomized, double-blind studies evaluating the efficacy of cannabidiol (CBD) for the treatment of DSM-5 anxiety disorders. These disorders include generalized anxiety disorder, social anxiety disorder, panic disorder, and agoraphobia. While lecithin is commonly used as an emulsifier in food and as a dietary supplement for potential benefits in brain health and lipid metabolism, its role in these specific psychiatric trials is to serve as an inactive comparator to assess the therapeutic and neuro-cognitive effects of CBD.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sunflower lecithin.